Native elongating transcript sequencing in human uncovers convergent sense and antisense transcription within promoterproximal regions of lower-expressed genes and unravels details about Pol II pausing. 
INTRODUCTION
High-throughput sequencing analyses of transcription have discovered new classes of RNAs and new levels of regulatory complexity. Many of these results were obtained with two experimental strategies to measure RNA polymerase density genome wide. The first, RNA polymerase II (Pol II) ChIP-seq or ChIP-chip, identifies DNA bound to RNA polymerase. The second set of approaches, global run-on sequencing (GRO-seq) and precision nuclear run-on and sequencing (PRO-seq), restarts RNA polymerase in vitro with labeled nucleotides to purify and sequence nascent RNA (Core et al., 2008; Kwak et al., 2013) . GRO-seq and Pol II ChIP detect strong transcriptional pauses $50 bp downstream of many transcription start sites, demonstrating that promoter-proximal pausing is more prevalent than initially observed (Core et al., 2008; Krumm et al., 1992; Kwak et al., 2013; Muse et al., 2007; Rahl et al., 2010; Rougvie and Lis, 1988; Strobl and Eick, 1992; Zeitlinger et al., 2007) . Abundant unstable transcripts upstream of and antisense to promoters revealed that divergent transcription is a common feature of eukaryotic promoters (Core et al., 2008; Neil et al., 2009; Preker et al., 2008; Seila et al., 2008; Xu et al., 2009) . Despite progress in understanding how these transcripts are terminated and degraded (Almada et al., 2013; Ntini et al., 2013; Preker et al., 2008; Schulz et al., 2013) , their roles remain unknown . Finally, recent studies confirm that splicing is largely co-transcriptional and splicing outcome is kinetically tied to elongation rate (Bhatt et al., 2012; Davis-Turak et al., 2015; Dujardin et al., 2014; Fong et al., 2014; Ip et al., 2011; de la Mata et al., 2003; Roberts et al., 1998; Shukla et al., 2011; Tilgner et al., 2012) . However, it has been impossible to determine whether such kinetic coupling in human cells is mediated by pausing events genome wide, due to the high resolution required to measure pausing on short human exons.
The strongly stereotyped locations of promoter-proximal pauses and divergent antisense transcription can be exposed by averaging Pol II density from many genes (metagene analysis) obtained at low resolution (Core et al., 2008; Neil et al., 2009; Preker et al., 2008; Rahl et al., 2010; Seila et al., 2008; Xu et al., 2009 ). Yet, the precise architecture of promoter-associated transcriptional activity and of pausing outside of promoter regions has been obscured by the resolution limitations of current methodologies, preventing deeper insight into the underlying regulatory mechanisms. Indeed, the interplay between chromatin structure, transcription factors, and the transcription machinery is largely undefined. Pol II ChIP-seq is typically limited in its resolution to >200 bp resolution and lacks strand specificity. GRO-seq is similarly limited to $50 bp resolution, and although PRO-seq has higher resolution, both runon methods require transcription elongation complexes to resume polymerization in vitro, a variable process sensitive to the experimental conditions and the Pol II pausing state (Core et al., 2008; Weber et al., 2014) . Recently, we showed that the extraordinary stability of the RNA-DNA-RNA polymerase ternary complex can be exploited to capture nascent RNA (Churchman and Weissman, 2011) . Native elongating transcript sequencing (NET-seq) quantitatively purifies Pol II complexes and sequences the 3 0 end of nascent RNA to reveal the strand-specific position of Pol II with single-nucleotide resolution. NET-seq detects all transcriptionally engaged Pol II, including productively transcribing Pol II, paused Pol II, and Pol II recovering from pausing (Churchman and Weissman, 2011) .
Here, we develop a NET-seq approach that quantitatively defines the full spectrum of transcriptional activity in a strand-specific manner and at nucleotide resolution in human cells. We find that many promoters display antisense transcription downstream of a promoter-proximal pause, resulting in convergent sense and antisense transcriptional activities that face one another in close proximity. Convergent transcription is associated with a distinct chromatin conformation and is a feature of lower-expressed genes, suggesting a possible regulatory role. NET-seq reveals that Pol II density profiles differ between retained exons, skipped exons, and introns in human cells, indicating generalized kinetic coupling of transcription and splicing. Human NET-seq is readily applicable to diverse cell types and provides a general strategy to study transcriptional complexity.
RESULTS

A Robust Human NET-Seq Methodology
The first step of NET-seq purifies nascent RNA through its tight interaction with RNA polymerase. In yeast, this is achieved through an epitope-tagged Pol II subunit that enables highly quantitative purification and specific elution (Churchman and Weissman, 2011) . In adapting NET-seq to human cells, we biochemically purify >99% of all engaged RNA polymerase in a highly specific manner that can be applied to any mammalian cell line or tissue without genetic modification ( Figure 1A ). This method avoids using Pol II antisera, which could bias the population of isolated Pol II complexes due to posttranslational modifications and epitope masking by heterogeneous Pol II binding partners and structural conformations. Instead, human NETseq exploits the high stability of the RNA-DNA-RNA polymerase ternary complex, even in the presence of high salt and urea (Cai and Luse, 1987; Wuarin and Schibler, 1994) , to purify engaged RNA polymerase, along with its nascent RNA, through an association with chromatin after cellular fractionation into cytoplasm, nucleoplasm, and chromatin (Bhatt et al., 2012; Pandya-Jones and Black, 2009; Wuarin and Schibler, 1994) . To prevent transcriptional run-on during fractionation, lysate is kept at %4 C, and a-amanitin, a potent transcriptional inhibitor (Lindell et al., 1970) , is included in every step. Through optimization of current correlation, R = 0.97). 0.5 pseudocounts were added to genes with zero counts in one of the replicates. The data set with higher coverage was randomly downsampled to match the total number of reads of the other data set. See also Figure S1 and Table S1 .
fractionation approaches, we identified buffers and washing conditions that cleanly purify >99% of elongating RNA polymerase II (C-terminal domain [CTD] Ser2-P, Ser5-P, and the general CTD hyper-phosphorylated form of Pol II) in the chromatin fraction (see Experimental Procedures and Figures 1B and S1A ). Western blot analyses of Pol II isoforms and factors with welldefined subcellular localizations verify the stringency of our fractionation conditions ( Figure 1B ). To confirm that our purification strategy specifically isolates nascent RNA, we sequenced the RNA in each fraction. Unprocessed RNA species, such as intron-containing Pol II transcripts and spacer-containing Pol I transcripts ( Figures 1C and S1B ), are heavily enriched in the chromatin fraction. Importantly, the large majority of intron-containing RNAs observed in the nucleoplasm persist to the cytoplasm, indicating that these RNAs are products of intron-retaining alternative splicing and not nascent transcripts ( Figure S1C ). Together, these results demonstrate that RNA polymerase and nascent RNA are quantitatively purified through the isolation of chromatin.
The second step of the NET-seq approach requires sequencing the 3 0 ends of the nascent RNA, which localizes Pol II genome wide at nucleotide resolution (Churchman and Weissman, 2011; Ferrari et al., 2013; Weber et al., 2014) . In large part, our yeast library construction protocol is used (Churchman and Weissman, 2012) , with two important changes to account for the increased complexity of the human genome. First, we addressed reverse transcription (RT) artifacts that arise from the significant size of human nascent RNA. We found that reverse transcription frequently initiates within the RNA if there are stretches as short as six nucleotides of complementarity to the RT primer ( Figure S1D ). When the 3 0 ends of the nascent RNA are ligated to a linker pool, consisting of a random hexamer at the 5 0 end followed by a common sequence, ligation efficiency increases and mispriming events are dramatically reduced (Figure S1D) . Furthermore, the hexamer serves as a molecular barcode for each molecule and enables the computational removal of reads arising from residual mispriming events and PCR duplicates. Second, we deplete abundant mature snRNAs, snoRNAs, rRNA, and others through subtractive hybridization targeting their 3 0 ends ( Figure S1E , Table S1 ) to increase sequencing coverage for nascent transcripts. Finally, library construction steps are optimized to be highly efficient (>90%) and are continually monitored through quality controls to minimize bias. Together, our optimized library construction protocol faithfully converts the 3 0 ends of nascent human RNA to a DNA sequencing library that allows the high-fidelity mapping of strand-specific Pol II density.
To observe genome-wide transcriptional activity, a NET-seq library was prepared from HeLa S3 cells and sequenced to high coverage (768 million total reads, 360 million uniquely aligned). Each sequencing read was aligned to the human genome, and the genomic location of the 3 0 end of the nascent RNA was recorded to map RNA polymerase density with nucleotide resolution. As expected, we recovered nascent RNA from all three nuclear RNA polymerases (Pol I, Pol II, Pol III), as well as mature chromatin-associated RNAs, such as snRNAs, and splicing intermediates (Figures S1F and S1G) . Here, we focused our analysis on Pol-II-synthesized RNAs, but our results suggest that the NET-seq approach is amenable to the study of other RNA polymerases. Importantly, comparison of a biological replicate library (175 million total reads, 83 million uniquely aligned) shows strong agreement, indicating the robustness of the approach (Pearson's coefficient, 0.97, Figure 1D ). To demonstrate that NET-seq is easily adaptable to other cell lines, we applied our approach to HEK293T cells and obtained data from two replicates with similar reproducibility (replicate 1: 1.203 billion total reads, 555 million uniquely aligned; replicate 2: 358 million total reads, 135 million uniquely aligned; Figure S1H) . From these analyses, we conclude that human NET-seq is capable of quantitatively monitoring transcriptional activity across the human genome and adaptation to new cell lines is straightforward.
NET-Seq Reveals Transcriptional Activity at Nucleotide Resolution Genome Wide
The resolution afforded by NET-seq and the sequencing coverage obtained provide an in-depth view of genome-wide transcriptional activity. The highest coverage is observed across promoter-proximal regions, which we conservatively defined as the region between the earliest annotated transcription start site and +1 kb. Within this region, >50% of genes have coverage of >1 read per kb per million uniquely aligned reads (RPKM) in both HeLa S3 (Figures 2A and 2B ) and HEK293T cells (Figure S2C) . When coverage is calculated across entire genes, the percentage decreases to <30% in both cell lines due to the prevalence of promoter-proximal pausing (Figures 2A and 2B ). Indeed, most (89% in HeLa S3 cells and 94% in HEK293T cells) expressed genes display promoter-proximal pausing defined by a traveling ratio (coverage ratio between a narrow promoterproximal region and the gene body) of R2, consistent with earlier observations in mouse embryonic stem cells (Figures 2C and S2D) (Rahl et al., 2010) . Furthermore, we detect unstable RNA production, antisense transcription upstream of many promoters (89% in HeLa S3 cells and 82% in HEK293T cells), transcription downstream of many polyadenylation sites (95% in HeLa S3 cells and 88% in HEK293T cells), and enhancer RNAs (Figures S2A, S2B, S2E,and S2F).
NET-seq data describe transcriptional activity at many length scales. At the single-gene level, strong signal is observed at promoter regions and across introns ( Figure 2D , top and middle). Signal variation across the gene body suggests that transcription elongation is discontinuous following release from promoterproximal regions and that pausing is a general feature during productive Pol II transcription. Near transcription start sites (TSSs), NET-seq detects sense and antisense transcription of divergent promoters at single-nucleotide resolution, revealing that promoter-proximal pausing does not occur at only one position; instead, there are narrow regions of high Pol II density ( Figure 2D , bottom). Together, NET-seq data uncover key features of human transcription activity, and the high resolution and the coverage of the data provide deeper insight into these complexities.
Widespread Convergent Transcription in PromoterProximal Regions
Several previous studies showed widespread divergent transcription at eukaryotic promoters (Churchman and Weissman, 2011; Core et al., 2008; Neil et al., 2009; Seila et al., 2008; Xu et al., 2009 ). We analyzed this phenomenon for a stringently defined set of Pol-II-transcribed genes that do not overlap other genes within 2.5 kb of the TSS and polyadenylation site and are longer than 2 kb to avoid misinterpreting transcription from other genes as antisense transcription (n = 3,937 genes). Analysis of regions 2 kb upstream and downstream of transcription start sites with broad coverage and no sign of missing overlapping annotation (n = 1,488; see Experimental Procedure) reveals divergent transcription in 77% of promoter-proximal regions, consistent with other studies ( Figure 3A , left) (Core et al., 2008; Seila et al., 2008) . Surprisingly, close inspection of our data revealed an unappreciated form of antisense transcription near promoters. At 25% of promoter-proximal regions, we observe antisense transcription originating downstream of sense transcription ( Figure 3A , right), which we term convergent transcription. Convergent transcription is clearly observed at single-promoter regions (Figures 3B and 3C) , and in most cases, such as near the KLHL9 promoter, convergent transcription is accompanied by divergent transcription ( Figure 3B ). However, it also occurs in the absence of divergent transcription (for example, FAM133B, Figure 3C ). Furthermore, GRO-seq also detects these transcripts. A re-analysis of mouse embryonic stem cell data reveals convergent antisense transcription (Jonkers et al., 2014) (Figure S3A ).
To characterize the structural attributes on these modes of transcriptional activity, distances between sense and antisense peaks were determined for each promoter-proximal region (Figure 3D) . A stereotypical distance (250 ± 50 bp) separates the sense and antisense peaks in divergent transcription, while the sense and antisense peaks in convergent transcription are also separated by a stereotypical distance (150 bp ± 50 bp), indicating that convergent antisense transcription is not simply the result of spurious antisense transcription initiation events across the promoter-proximal region ( Figure 3D ).
A Distinct Chromatin Structure Associated with Convergent Transcription
Many chromatin modifiers control antisense transcription (Churchman and Weissman, 2011; DeGennaro et al., 2013; Kim et al., 2012; Marquardt et al., 2014; Whitehouse et al., 2007) , and we asked how promoter-proximal transcriptional Figure 2A . (C) Distributions of the percent of well-expressed Pol II protein-coding genes (n = 8,912) with a given traveling ratio. Well-expressed Pol II genes are defined as those genes with an RPKM of 1 or greater in a tight promoter-proximal region (À30 bp to +300 bp of the TSS). Traveling ratio (TR) is defined as the RPKM of the tight promoter-proximal region divided by the RPKM of the gene body region. (D) Number of NET-seq reads at three zoom levels around the PRPF38B locus for HeLa S3 cells. Reads that aligned to the positive strand (+) are in violet, and reads that aligned to the negative strand (À) are in red. The TSS and the direction of transcription are indicated by an arrow. Annotation of exonic and intronic regions is shown as boxes and lines, respectively. RPKM, reads per kb per million uniquely aligned reads at Pol-II-transcribed genes; TSS, transcription start site; pA, polyadenylation site. See also Figure S2 . activity relates to local chromatin structure. We used DNase-seq to map regions of open chromatin and highly positioned nucleosomes in the same HeLa S3 cells used for NET-seq (Thurman et al., 2012) . We examined the distribution of DNase I accessibility relative to promoter-proximal peaks in NET-seq data (A) Promoters are classified depending on whether they contain a peak of convergent antisense Pol II transcription, as illustrated by the cartoon above the heat maps. A stringent set of promoter-proximal regions was selected for analysis to ensure that transcription arising from other transcription units would not bias classification (see Experimental Procedures). Heatmaps of Pol II scaled density are displayed for each class (left, no convergent peak, n = 931 genes; right, convergent peak, n = 373). For each gene, the sense (violet) and antisense (red) raw signal is analyzed separately and normalized to vary from 0 to 1. Both signals are superposed, centered on the major sense transcription peak. Genes are sorted by the distance between the sense and antisense peaks. Mean Pol II density profile is displayed below the heatmaps, where raw sense and antisense data are normalized together to vary between 0 and 1 and smoothed with a 50 bp sliding window average. Solid lines indicate the mean values, and shading shows the 95% confidence interval. Sense transcription is shown in violet, and antisense transcription is shown in red. (B and C) Examples of NET-seq reads in two promoter-proximal regions that display convergent Pol II transcription. (D) Histogram of distances between the major peak of Pol II density in the sense direction and the peak(s) in the antisense direction for all promoters with convergent and/or divergent peaks (n = 1,304). (E) Distributions of the percentage of genes with a given Pol II density in the gene body region, as defined in Figure 2A . Genes with only convergent transcription (yellow, n = 151) or only divergent transcription (blue, n = 931) in their promoterproximal regions are compared. The p value is calculated by the Kolmogorov-Smirnov test. RPKM, reads per kb per million uniquely aligned reads at Pol-II-transcribed genes. See also Figure S3 . (Figure 4) . At genes that have a sense Pol II peak (representing promoter-proximally paused Pol II), we observe strong DNase I hypersensitivity upstream of the peak, determining the canonical promoter ( Figure 4A ), and reduced DNase sensitivity downstream of the peak corresponding to the +1 nucleosome. Thus, promoter-proximal pausing occurs prior to the +1 nucleosome in mammalian cells. Comparison of DNase I data relative to the divergent antisense peak shows that this transcriptional activity originates from the 5 0 side of the promoter hypersensitivity region, consistent with the model that divergent antisense transcription is a consequence of an open chromatin region (Seila et al., 2009) (Figure 4C) . In contrast, genes with convergent transcription show two distinct peaks in DNase I hypersensitivity: a canonical promoter peak and a downstream peak located proximal to the convergent antisense peak (Figure 4B) . Thus, convergent antisense transcription likely originates locally. Furthermore, the dip between the two peaks of DNase I hypersensitivity likely represents the +1 nucleosome, consistent with the $150 bp spacing between the sense and convergent antisense Pol II peaks ( Figures 3D and 4B ). These results indicate that convergent transcription reflects sense and antisense transcription that initiates locally and undergoes promoter-proximal pausing flanking the +1 nucleosome.
Convergent Transcription Is a Feature of LowerExpressed Genes
Convergent transcription can regulate gene expression through transcriptional interference mechanisms (Callen et al., 2004; Elledge and Davis, 1989; Gullerova and Proudfoot, 2012; Hobson et al., 2012; Martens et al., 2004; Prescott and Proudfoot, 2002; Shearwin et al., 2005) . Thus, we considered whether promoterproximal convergent transcription may be involved in release of Pol II from promoter-proximal pausing into productive elongation. We compared Pol II density within the gene body (+1 kb after the transcription start site to the polyadenylation site, illustrated in Figure 2A ) at genes that display only convergent transcription to genes that display only divergent transcription. Notably, genes with only convergent transcription near their promoters show consistently less transcription downstream of their promoter regions ( Figure 3E ) (1.8-fold less on average, Kolmogorov-Smirnov test, p < 10 À6 ). Comparison of less stringently defined sets of genes, such as all genes with convergent transcription to all genes without convergent transcription, showed a similar effect ( Figure S3B ). In agreement with this observation, analysis of ENCODE HeLa S3 ChIP-seq data reveals that H3K79me2 histone marks, which correlate with transcription elongation, occur at significantly lower levels in the gene bodies of genes with convergent antisense transcription ( Figure S3C ) (Consortium, 2012; Guenther et al., 2007; Wozniak and Strahl, 2014) . Thus, convergent antisense transcription could interfere with productive transcription elongation or could be a consequence of less-productive elongation. Either of these possibilities could be directly mediated by Pol II or by another factor, such as chromatin. To test whether convergent antisense transcription is a consequence of reduced sense transcription elongation, we globally suppressed productive elongation by inhibiting positive transcription elongation factor b (P-TEFb). Most promoter-proximally paused Pol II are released through recruitment of P-TEFb that phosphorylates multiple proteins, including Ser2 residues of the Pol II CTD (Kim and Sharp, 2001; Peterlin and Price, 2006) . Therefore, active P-TEFb greatly facilitates the transition to productive elongation but does not affect transcription initiation (Lis et al., 2000; Peterlin and Price, 2006; Rahl et al., 2010) . We performed NET-seq analysis on HeLa S3 cells exposed to the P-TEFb inhibitor flavopiridol (FP) (Chao and Price, 2001) or DMSO alone. As expected, after 60 min, FP reduced Pol II CTD Ser2 phosphorylation, but phosphorylation of Ser5 residues and overall Pol II levels remained unchanged ( Figures 5A and S4 ). We generated NET-seq libraries from HeLa S3 cells after a 1 hr FP treatment or DMSO control (FP treatment NET-seq data set, 486 million total reads, 262 uniquely mapped reads; DMSO control NET-seq data set, 491 million total reads, 263 million uniquely mapped). In agreement with previous studies, we observe a global decrease in Pol II density outside of promoter-proximal regions compared to the DMSO control ( Figure 5B , arrows) (Flynn et al., 2011; Jonkers et al., 2014; Rahl et al., 2010) . Thus, FP treatment reduces productive elongation of most genes. To quantify the effect of FP treatment on convergent transcription, we calculated the ratio of convergent antisense to sense transcription at all promoter-proximal regions. If convergent transcription were a simple consequence of lower expression, it should not only be increased proportionally to promoter-proximal sense transcription following FP treatment, but importantly, it should appear in genes where it was not detected before. We observe that the convergent antisense-to-sense transcription ratio remains constant following FP treatment, indicating that sense and convergent antisense transcription levels covary, and we do not detect a new subpopulation of genes with convergent transcription in their promoterproximal regions ( Figure 5C ). This result suggests that the lack of sense-productive transcription elongation is not sufficient to induce convergent transcription. Thus, if convergent antisense transcription is not a simple consequence of low sense expression, then it may contribute to the cause.
Impact of Transcription Factor Occupancy on Pol II Elongation DNA-bound transcription factors (TFs) have the potential to obstruct elongating Pol II. To investigate the relationship between TF occupancy and Pol II progress, we expanded our (B) Meta-gene analysis of NET-seq data from HeLa S3 cells treated with 1 mM FP (purple and red) or DMSO control (gray) for 1 hr. Arrows indicate regions where transcription is affected by FP treatment. Genes that had convergent and/or divergent peaks (described in Experimental Procedures) in both data sets are included in the analysis (n = 615). NETseq signal from each promoter region (± 2.5 kb centered at the sense transcription peak) are binned into 10 bp windows. For each sample, sense and antisense signal are normalized together to vary between 0 and 1 and then smoothed with a 50 bp sliding window. Solid lines indicate the mean normalized Pol II density, and shading shows the 95% confidence interval. (C) A scatterplot comparing the convergent-to-sense ratio after treatment with DMSO (control) and after FP treatment for a stringent subset of non-overlapping genes with at least 10 reads across the 500 bp region after TSS in both samples (n = 1,667). The ratio is the sum of NET-seq signal on the antisense strand versus the sense strand across the 500 bp region after the TSS. The handful of genes with a ratio of 0 are not plotted. TSS, transcription start site. See also Figure S4 .
DNase-seq data from HeLa S3 cells to genomic footprinting depth (269 million uniquely mapped genomic reads), enabling detailed mapping of the occupancy of TF recognition sites within DNase I hypersensitivity sites (DHSs). As CTCF is implicated in Pol II pausing in vitro and within the cell (Shukla et al., 2011) , we quantified NET-seq signal and DNase-seq signal around CTCF recognition sites within DHSs on both strands. We observed higher Pol II density just upstream of the CTCF sites, suggesting that CTCF might represent a barrier to Pol II elongation genome wide ( Figures 6A and 6B) . Interestingly, the NETseq signal around these sites differs in magnitude for each strand, indicating that CTCF may pose strand-specific obstacles ( Figure 6A ).
As transcriptional pausing has been seen upstream of nucleosomes in yeast and Drosophila cells (Churchman and Weissman, 2011; Mavrich et al., 2008; Weber et al., 2014) , we investigated Pol II density around YY1, a canonical promotercentric transcription factor (Xi et al., 2007) thought to position +1 nucleosomes (Vierstra et al., 2014) . Thus, we speculated that YY1 occupancy might impact Pol II elongation. Given that poly-zinc finger TFs engage DNA asymmetrically, we also speculated that any impact on Pol II might also be strand specific. We observed a peak in NET-seq signal precisely at YY1 sites in DHSs, consistent with YY1-directed pausing ( Figures 6C and  6D) . Strikingly, this effect was highly directional and is predominant when Pol II engages YY1 from the upstream direction (Figure 6D) . These results indicate that TFs might directly regulate Pol II elongation in direction-or strand-specific ways. 2014; Ip et al., 2011; de la Mata et al., 2003; Roberts et al., 1998) . However, the degree to which transcription rate is modulated locally around exons is unclear. Higher Pol II density at human exons versus introns was reported using Pol II ChIP-seq and ChIP-chip (Brodsky et al., 2005; Schwartz et al., 2009 ), but in another study, no significant difference was observed (Spies et al., 2009) . Furthermore, the precise pattern across individual exons could not be resolved. In Drosophila cells, PRO-seq observed high Pol II density across exons and detected a high enrichment of Pol II density at the 5 0 ends (Kwak et al., 2013) . (B) A stringent set of exons was selected for analysis from genes containing NET-seq signal of R1 RPKM (B, see Experimental Procedures). Heatmaps and metaexon analysis of HeLa S3 Pol II density across each type of exon, as defined in (A) (left to right: constitutive exons, n = 1,334; alternative retained, n = 14,582; and alternative skipped, n = 6,348). NET-seq signal from each exon (± 25 bp) is normalized to vary from 0 to 1 (white to black scale in the heatmaps). Solid lines on the meta-exon plots indicate the mean values, and the gray shading represents the 95% confidence interval. The single-nucleotide positions where splicing intermediates align (3 0 ends of introns and exons) were entirely removed from analysis (see Experimental Procedures) and appear as a blank position in the figures.
(C-E) Raw NET-seq reads across the constitutive exon 2 within the DDX3X gene (C), alternative retained exon 2 within the SIK1 gene (D), and the alternative skipped exon 10 within the CD55 gene (E).
(F) Distribution of the percent of exons or introns with a given Pol II density. RPKM, reads per kb per million Pol II uniquely aligned reads. See also Figure S5 .
We analyzed NET-seq data at constitutive exons and revealed significantly higher coverage than at introns in both HeLa S3 (2.4 3 higher) and HEK293T cells (2.23 higher) (p < 10 À15 , Kolmogorov-Smirnov test), suggesting that transcription elongation is slower at exons in human cells ( Figures 7A, 7B, 7F and S5A ). Any contamination from processed mRNA would inflate these differences; however, our quality controls ( Figures 1B, 1C , and S1A) suggest that this is a small effect, if at all. Strikingly, NETseq signal across exons is not uniform: sharp increases in Pol II density occur in the few base pairs surrounding the 5 0 and 3 0 ends of constitutive exons, indicating strong Pol II pausing at exon boundaries ( Figure 7B ). As splicing intermediates are known NET-seq contaminants ( Figure S1G ), we removed the single bp positions where they align from analysis. Furthermore, a broader peak of RNA polymerase density is present $17 nt before the 3 0 end of exons. The general features of this pattern are observed at single exons, for example, exons 2 of the DDX3X and SIK1 genes ( Figures 7C and 7D ). Finally, we observe similar trends in the NET-seq data from HEK293T cells (Figure S5B ). This analysis suggests that exon borders impose a structured barrier to Pol II elongation.
Most human exons can be alternatively spliced, with retained exons varying between cell types (Pan et al., 2008; Wang et al., 2008) . We expanded our analysis to alternatively spliced exons and investigated whether transcriptional pausing varies at exons with different splicing outcomes. We focused our analysis on genes with a NET-seq RPKM of >1 in the gene body ( Figure S5A ) and defined skipped exons as those undetected in the cytoplasmic RNA-seq data ( Figure 7A ). As for constitutive exons, retained alternative exons have higher Pol II density compared to the density across introns ( Figure 7F ). These exons also have a similar pausing pattern as constitutive exons, which is visible by meta-exon analysis and at the single exon ( Figures 7B and 7D) . Interestingly, Pol II density is lower at skipped exons than at alternative retained exons ( Figure 7F) . Strikingly, the Pol II density pattern is similarly shaped across skipped and retained exons, albeit significantly different in amplitude ( Figures 7B and 7E ). The residual pausing pattern at skipped exons could be due to the small number of retained exons that are misannotated as skipped. Finally, the same differences in the Pol II density patterns across retained and skipped exons are observed in HEK293T cells ( Figure S5B ). Together, these data show that Pol II recognizes exon structures with different processing fates, suggesting that alternative splicing is kinetically coupled to transcription elongation genome wide.
DISCUSSION
Here, we demonstrate that human NET-seq provides complete, strand-specific maps of transcription at single-nucleotide resolution. NET-seq thereby defines transcriptional pausing sites and directly measures unstable transcripts. Finally, NET-seq instantaneously reports the transcription status of genes, in contrast to RNA-seq, which reports the balance between RNA synthesis and degradation.
Our work describes an unappreciated aspect of promoterproximal transcription: the presence of convergent transcription at many human genes. Importantly, we show that convergent transcription is characteristic of lower-expressed genes, suggesting a potential role in the regulation of promoter-proximal pausing. Prominent DNase I hypersensitivity sites flanking the convergent antisense peak indicate that promoter-proximal convergent transcription reflects initiation at a defined promoter located a characteristic distance from the canonical sense promoter.
Other than expression level, only one commonality is found between the genes with convergent transcription: the dinucleotide CC occurs slightly more frequently in regions displaying convergent transcription (12.4% ± 0.4% for convergent, 11.1% ± 0.2% for not convergent). Thus, it appears that convergent transcription is a prevalent phenomenon that is not restricted to a specific class of genes. An intriguing possibility is that paused antisense Pol II directly blocks or clashes with sense transcription, as can occur in yeast (Prescott and Proudfoot, 2002) . The sense and convergent antisense peaks are too far apart ($150 bp) to reflect direct contact of paused polymerases, but the DNase-seq data reveal that this distance likely represents the +1 nucleosome that is positioned between them. Interference could arise through positioning of the +1 nucleosome or indirect mechanisms such as transcription-induced changes in DNA topology, chromatin modifications, or transcription factor occupancy. In any event, NET-seq data do not resolve whether sense and antisense transcription occur simultaneously, as the approach requires averaging over a population of cells. Therefore, potential roles of convergent transcription during initiation, elongation, and termination will have to be investigated within cell populations and at the single-cell level.
Our study yields a global picture of how transcription elongation is altered at alternatively spliced exons in human cells. Changes in transcription elongation influence alternative splicing, which is thought to be mediated either by the differential recruitment of splicing factors (recruitment model) or by biasing kinetic competition between multiple splicing outcomes (kinetic model) (Bentley, 2014; Dujardin et al., 2013; Kornblihtt et al., 2004) . Here, we show that alternative splicing outcomes in human cells are associated with Pol II exon density and strong pauses at the 5 0 and 3 0 ends, consistent with the kinetic model. What causes pauses at exons is an important question. Nucleosomes can influence transcriptional pausing (Churchman and Weissman, 2011; Hodges et al., 2009; Izban and Luse, 1991; Skene et al., 2014) , and, importantly, nucleosome occupancy and histone modifications transition at exon boundaries according to splice site strength (Andersson et al., 2009; Chodavarapu et al., 2010; Huff et al., 2010; Schwartz et al., 2009; Spies et al., 2009; Tilgner et al., 2009) . DNA sequence and DNA methylation at exon boundaries could contribute to pausing because sequence elements have been shown to cause transcriptional pausing (Gelfman et al., 2013; Herbert et al., 2006; Kassavetis and Chamberlin, 1981; Larson et al., 2014; Maizels, 1973; Vvedenskaya et al., 2014) . Additionally, transcription factors could underlie pausing at retained exons, as is the case with CTCF binding at exon 5 of the CD45 gene (Shukla et al., 2011) . The broad peak of Pol II density 17 bp from the 3 0 end of the exon may reflect Pol II backtracking during the recovery from the strong pause at the 3 0 end of the exon. Backtracking would produce small cleavage products, consistent with the population of tiny RNAs that were previously identified in this region (Taft et al., 2009 ). We expect adaptation of human NET-seq to any human cell type to be straightforward, resulting in a tool to illuminate a variety of biological processes. Future applications include high-resolution analyses of transcription regulation across cell types, responses to signaling pathways, and cellular differentiation.
EXPERIMENTAL PROCEDURES Cell Fractionation and RNA Purification
Cell fractionation is performed as described by (Bhatt et al., 2012; PandyaJones and Black, 2009 ) and based on (Wuarin and Schibler, 1994 ) with modifications. All steps are conducted on ice or at 4 C and in the presence of 25 mM a-amanitin, 50 units/ml SUPERaseIN and Protease inhibitors cOmplete. HeLa S3 cells and HEK293T cells are grown in DMEM containing 10% FBS, 100 U/ml penicillin, and 100 mg/ml streptomycin to a confluency of 90%. Following lysis of 1 3 10 7 cells, the nuclei are washed with the nuclei wash buffer (0.1% Triton X-100, 1 mM EDTA, in 13 PBS) to remove cytoplasmic remnants. Nuclei lysis is performed without MgCl 2 (1% NP-40, 20 mM HEPES [pH 7.5], 300 mM NaCl, 1 M Urea, 0.2 mM EDTA, 1 mM DTT). The success of cell fractionation is monitored by western blot analysis and subcellular RNA-seq.
Sequencing Library Constructions
For NET-seq, the library preparation is performed as described by Weissman (2011, 2012) with modifications. For 3 0 RNA ligation, a pre-adenylated DNA linker with a mixed random hexameric barcode sequence at its 5 0 end is used. cDNA containing the 3 0 end sequences of a subset of mature and heavily sequenced snRNAs, snoRNAs, rRNAs, and mitochondrial tRNAs are specifically depleted using biotinylated DNA oligos (Table S1) , as described by Ingolia et al. (2012) . For subcellular RNA-seq, the sequencing libraries are prepared as described in Churchman and Weissman (2012) , with the ribosomal RNA removed using the Ribo-Zero Magnetic Kit (Epicentre). DNA libraries are sequenced by the NextSeq 500 and HiSeq 2000 Illumina platforms.
Processing and Alignment of Sequencing Reads
Reads are trimmed and aligned using STAR (v2.4.0) (Dobin et al., 2013) . For NET-seq data, only the position matching the 5 0 end of the sequencing read (after removal of the barcode), corresponding to the 3 0 end of the nascent RNA fragment, is recorded with a Python script using HTSeq package (Anders et al., 2015) . Reverse transcription mispriming events are identified and removed when molecular barcode sequences match exactly to the genomic sequence adjacent to the aligned read. Reads that align to the same genomic position and contain identical barcodes are considered PCR duplication events and are removed. Splicing intermediates have 3 0 hydroxyls and will enter NET-seq libraries and contribute to the reads aligning to the exact single-nucleotide 3 0 ends of introns and 3 0 ends of exons ( Figure S1G ). Therefore, reads that map precisely at the exact single-nucleotide ends of introns and exons are discarded, and the single 1 bp genomic positions are not considered in subsequent analysis.
Annotation of Exons and Introns
Clear exonic regions are identified by determining the minimum overlapping exonic region of all isoforms that have an exon at that position. If the region is present in all isoforms, it is considered a constitutive exon; otherwise, it is labeled alternative. Alternative skipped exons are classified by those alternative exons that are entirely undetected in the cytoplasm RNA-seq data, and the rest of the alternative exons are classified as retained. Constitutive intronic regions are identified as the minimum intronic overlapping regions present in all isoforms.
NET-Seq Exon Metagene and Heatmap Analysis
The set of exons included in the analysis are required to be within genes of an RPKM >1 in gene bodies (defined in Figure 2A ) and not overlapping any other annotated exon. They are required to begin and end at the same position in all isoforms that contain the exon. First and last exons of genes are removed from analysis. NET-seq signal across each exon ±25 bp is normalized to range between 0 and 1 so that each exon contributes to the analysis with the same weight. Precise single-nucleotide genomic loci where splicing intermediates map (exact 3 0 ends of introns and exons)
are not included in the analysis, and those locations are left blank in any plots.
Analysis of Promoter-Proximal Regions
Promoter-proximal regions were carefully selected for analysis to ensure that there is minimal contamination from transcription arising from other transcription units. Starting with genes that are Pol II protein coding, nonoverlapping within a region of 2.5 kb upstream of the TSS and 2.5 kb downstream of the polyA site, and longer than 2 kb, NET-seq data at promoter-proximal regions are required to have a coefficient of variation >0.5 and have at least 40 positions covered in the sense strand. Within a 4 kb window surrounding the TSS, peaks were identified in the sense from these genes. If >40 bases on the antisense strand have NET-seq signal, peaks were also identified on the antisense strand. Promoter regions with an antisense peak located downstream of the sense major peak are classified as displaying convergent transcription. Promoter regions with an antisense peak located upstream of the sense major peak are classified as displaying divergent transcription.
ACCESSION NUMBERS
All NET-seq and RNA-seq data sets are available at GEO under the accession number GSE61332. DNase-seq data sets are available at ENCODE under the ENCODE DCC accession number ENCBS229UDI. 
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